Congress Wealth Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-177,801
| Closed | -$6.06M | – | 739 |
|
|
2024
Q1 | $6.06M | Buy |
177,801
+48,750
| +38% | +$1.66M | 0.1% | 207 |
|
|
2023
Q4 | $3.73M | Sell |
129,051
-30,095
| -19% | -$871K | 0.07% | 251 |
|
|
2023
Q3 | $4.39M | Buy |
159,146
+6,502
| +4% | +$179K | 0.09% | 228 |
|
|
2023
Q2 | $4.59M | Buy |
152,644
+1,206
| +0.8% | +$36.3K | 0.11% | 199 |
|
|
2023
Q1 | $5.49M | Buy |
151,438
+17,486
| +13% | +$634K | 0.13% | 178 |
|
|
2022
Q4 | $4.78M | Sell |
133,952
-3,644
| -3% | -$130K | 0.12% | 184 |
|
|
2022
Q3 | $4.66M | Sell |
137,596
-1,138
| -0.8% | -$38.5K | 0.13% | 186 |
|
|
2022
Q2 | $4.01M | Sell |
138,734
-4,111
| -3% | -$119K | 0.1% | 209 |
|
|
2022
Q1 | $4.62M | Buy |
142,845
+28,999
| +25% | +$937K | 0.1% | 215 |
|
|
2021
Q4 | $3.32M | Buy |
+113,846
| New | +$3.32M | 0.07% | 265 |
|